EHA: European Hematology Association

Conference Coverage

Inhibitor elicits responses in cGVHD

STOCKHOLM—The ROCK2 inhibitor KD025 produced responses in about two-thirds of patients with steroid-dependent or refractory chronic graft-versus-...

Conference Coverage

MAb doubles ORR, PFS in rel/ref MM

STOCKHOLM—Adding elotuzumab (E) to treatment with pomalidomide (P) and low-dose dexamethasone (d) can produce “clinically meaningful” results in...

Conference Coverage

Umbralisib can revitalize ruxolitinib in MF

STOCKHOLM—The PI3K delta inhibitor umbralisib can “augment or resurrect” responses to ruxolitinib in patients with myelofibrosis (MF), according...

Pages